Skip to main content
Top
Published in: Medical Oncology 1/2011

01-03-2011 | Letter to the Editor

Acute promyelocytic leukemia in a young patient with breast cancer

Authors: Ozgur Kara, Evren Ozdemir, Cagatay Arslan, Erkan Dogan, Kadri Altundag

Published in: Medical Oncology | Issue 1/2011

Login to get access

Excerpt

To the Editor, …
Literature
1.
go back to reference Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.CrossRef Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.CrossRef
2.
go back to reference Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood. 1995;8(6):3542–52. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood. 1995;8(6):3542–52.
3.
go back to reference Bhatia P, Das R, Ahluwalia J, et al. Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India. Indian J Pathol Microbiol. 2009;52:167–70.PubMedCrossRef Bhatia P, Das R, Ahluwalia J, et al. Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India. Indian J Pathol Microbiol. 2009;52:167–70.PubMedCrossRef
4.
go back to reference Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet. 1991;55:119–24.PubMedCrossRef Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet. 1991;55:119–24.PubMedCrossRef
5.
go back to reference Smith RE. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project Experience. Clin Breast Cancer. 2003;4:273–9.PubMedCrossRef Smith RE. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project Experience. Clin Breast Cancer. 2003;4:273–9.PubMedCrossRef
6.
go back to reference Smith SM, Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102:43–52.PubMedCrossRef Smith SM, Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102:43–52.PubMedCrossRef
7.
go back to reference Pagano L, Pulsoni A, Mele L, et al. Acute myeloid leukaemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group. Ann Oncol. 2001;12:203–7.PubMedCrossRef Pagano L, Pulsoni A, Mele L, et al. Acute myeloid leukaemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group. Ann Oncol. 2001;12:203–7.PubMedCrossRef
8.
go back to reference Lee KD, Chen SC, Chan CH, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev. 2008;17:2647–55.PubMedCrossRef Lee KD, Chen SC, Chan CH, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev. 2008;17:2647–55.PubMedCrossRef
9.
go back to reference Hall MJ, Li L, Wiernik PH, et al. BRCA2 mutation and the risk of hematologic malignancy. Leuk Lymphoma. 2006;47:765–7.PubMed Hall MJ, Li L, Wiernik PH, et al. BRCA2 mutation and the risk of hematologic malignancy. Leuk Lymphoma. 2006;47:765–7.PubMed
10.
go back to reference Moskowitz C, Dutcher JP, Wiernik PH. Association of thyroid disease with acute leukemia. Am J Hematol. 1992;39:102–7.PubMedCrossRef Moskowitz C, Dutcher JP, Wiernik PH. Association of thyroid disease with acute leukemia. Am J Hematol. 1992;39:102–7.PubMedCrossRef
Metadata
Title
Acute promyelocytic leukemia in a young patient with breast cancer
Authors
Ozgur Kara
Evren Ozdemir
Cagatay Arslan
Erkan Dogan
Kadri Altundag
Publication date
01-03-2011
Publisher
Springer US
Published in
Medical Oncology / Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9437-z

Other articles of this Issue 1/2011

Medical Oncology 1/2011 Go to the issue